Astrana Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Astrana Health
ASTH Stock   24.97  0.21  0.83%   
Astrana Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Astrana Health's valuation are provided below:
Gross Profit
297 M
Profit Margin
0.0033
Market Capitalization
1.3 B
Enterprise Value Revenue
0.6554
Revenue
2.9 B
We have found one hundred twenty available fundamental signals for Astrana Health, which can be analyzed and compared to other ratios and to its rivals. Traders should compare all of Astrana Health prevailing fundamentals against the fundamentals between 2010 and 2025 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 1 B. Enterprise Value is estimated to decrease to about 1.1 B

Astrana Health Total Revenue

2.14 Billion

Check Astrana Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Astrana Health's main balance sheet or income statement drivers, such as Interest Expense of 34.8 M, Other Operating Expenses of 2 B or Operating Income of 93.8 M, as well as many indicators such as Price To Sales Ratio of 1.18, Dividend Yield of 0.0026 or PTB Ratio of 2.45. Astrana financial statements analysis is a perfect complement when working with Astrana Health Valuation or Volatility modules.
  
Build AI portfolio with Astrana Stock
Check out the analysis of Astrana Health Correlation against competitors.
For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.

Astrana Health Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.4 B1.4 B509.9 M
Slightly volatile
Other Current Liabilities338.6 M322.5 M84 M
Slightly volatile
Total Current Liabilities383.9 M365.6 M104 M
Slightly volatile
Accounts Payable15.9 M15.2 M7 M
Slightly volatile
Cash302.9 M288.5 M122.7 M
Slightly volatile
Cash And Short Term Investments305.4 M290.8 M138.5 M
Slightly volatile
Common Stock Total Equity30 K54 K32.4 K
Slightly volatile
Common Stock Shares Outstanding50.6 M48.2 M28.8 M
Slightly volatile
Liabilities And Stockholders Equity1.4 B1.4 B509.9 M
Slightly volatile
Non Current Liabilities Total498.9 M475.1 M150.4 M
Slightly volatile
Other Stockholder Equity447.7 M426.4 M171.9 M
Slightly volatile
Total Liabilities882.8 M840.7 M254.4 M
Slightly volatile
Total Current Assets670.4 M638.5 M227.3 M
Slightly volatile
Common Stock34.2 K48 K35.3 K
Slightly volatile
Short and Long Term Debt Total495.4 M471.8 M142.7 M
Slightly volatile
Short Term Debt16 M15.3 M6.5 M
Slightly volatile
Property Plant And Equipment Net25.4 M46.9 M26.2 M
Slightly volatile
Non Current Assets Total752.2 M716.4 M282.6 M
Slightly volatile
Non Currrent Assets Other66.4 M63.2 M11.6 M
Slightly volatile
Net Receivables341 M324.8 M80.4 M
Slightly volatile
Other Current Assets24 M22.9 M8.5 M
Slightly volatile
Property Plant And Equipment Gross75.1 M71.6 M32.2 M
Slightly volatile
Current Deferred Revenue1.5 M1.6 M3.6 M
Slightly volatile
Long Term Debt446.6 M425.3 M125.7 M
Slightly volatile
Good Will440.2 M419.3 M157 M
Slightly volatile
Long Term Debt Total245.6 M233.9 M97.1 M
Slightly volatile
Capital Surpluse434.8 M414.1 M169.8 M
Slightly volatile
Intangible Assets62.1 M118.2 M49.7 M
Slightly volatile
Property Plant Equipment155.7 M148.3 M46 M
Slightly volatile
Other Liabilities28.2 M21 M27 M
Very volatile
Short and Long Term Debt6.2 M9.4 M5.9 M
Pretty Stable
Long Term Investments39.7 M48.2 M29.1 M
Slightly volatile
Non Current Liabilities Other14.7 M14 M13.2 M
Slightly volatile
Warrants11.7 M12.3 M124.5 M
Slightly volatile
Capital Lease Obligations21.7 M37.2 M11.5 M
Slightly volatile
Net Invested Capital659.9 M1.1 B413.6 M
Slightly volatile
Net Working Capital229.6 M272.9 M133.8 M
Slightly volatile
Capital Stock47.1 K48 K38.9 K
Slightly volatile

Astrana Health Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses2 B1.9 B551.7 M
Slightly volatile
Selling General Administrative161.8 M154.1 M46.6 M
Slightly volatile
Total Revenue2.1 B2 B590.1 M
Slightly volatile
Cost Of Revenue1.9 B1.8 B496.4 M
Slightly volatile
Depreciation And Amortization29.3 M27.9 M11.7 M
Slightly volatile
Gross Profit285 M271.4 M93.7 M
Slightly volatile
Interest Income15.2 M14.5 M3.9 M
Slightly volatile
Non Recurring539.2 K567.6 K2 M
Slightly volatile
Reconciled Depreciation21.5 M27.9 M19.5 M
Slightly volatile
Extraordinary Items7.8 M8.7 M9.5 M
Slightly volatile

Astrana Health Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow308.9 M294.2 M105.1 M
Slightly volatile
End Period Cash Flow303.6 M289.1 M122.4 M
Slightly volatile
Depreciation29.3 M27.9 M11.7 M
Slightly volatile
Stock Based Compensation36.3 M34.5 M8.3 M
Slightly volatile
Dividends Paid3.8 M4 M16.2 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.180.7391.0108
Slightly volatile
Dividend Yield0.00260.00270.0248
Very volatile
PTB Ratio2.452.10962.1111
Slightly volatile
Days Sales Outstanding35.5858.2738.8717
Slightly volatile
Book Value Per Share10.2410.78226.2 M
Slightly volatile
Stock Based Compensation To Revenue0.01040.0170.0104
Slightly volatile
Capex To Depreciation0.470.28760.6028
Very volatile
PB Ratio2.452.10962.1111
Slightly volatile
Payables Turnover58.711650.8899
Slightly volatile
Sales General And Administrative To Revenue0.05620.07570.0715
Pretty Stable
Capex To Revenue0.00790.00390.0082
Slightly volatile
Cash Per Share5.796.09886.7 M
Slightly volatile
Days Payables Outstanding2.983.1414.5912
Slightly volatile
Income Quality1.031.04540.9778
Slightly volatile
EV To Operating Cash Flow20.3332.318317.6968
Slightly volatile
EV To Free Cash Flow25.1438.194821.2095
Slightly volatile
Intangibles To Total Assets0.290.39670.2688
Slightly volatile
Current Ratio1.941.74642.1404
Slightly volatile
Receivables Turnover10.16.263910.353
Slightly volatile
Graham Number11.217.443713.2374
Slightly volatile
Shareholders Equity Per Share14.214.94584.2 M
Slightly volatile
Debt To Equity0.380.6620.307
Slightly volatile
Capex Per Share0.160.1684188.6 K
Slightly volatile
Average Receivables46.8 M70.4 M53.6 M
Slightly volatile
Revenue Per Share40.5342.664631.7 M
Slightly volatile
Interest Debt Per Share10.0610.5886525.9 K
Slightly volatile
Debt To Assets0.370.34820.1445
Slightly volatile
Enterprise Value Over EBITDA11.0811.89329.3213
Slightly volatile
Operating Cycle35.5858.2738.8717
Slightly volatile
Price Book Value Ratio2.452.10962.1111
Slightly volatile
Days Of Payables Outstanding2.983.1414.5912
Slightly volatile
Ebt Per Ebit1.130.90451.1269
Slightly volatile
Effective Tax Rate0.30.38220.2342
Slightly volatile
Company Equity Multiplier2.771.9012.8357
Slightly volatile
Long Term Debt To Capitalization0.260.37370.191
Slightly volatile
Total Debt To Capitalization0.220.39830.1822
Slightly volatile
Debt Equity Ratio0.380.6620.307
Slightly volatile
Quick Ratio1.941.74642.1404
Slightly volatile
Cash Ratio1.120.7891.3149
Pretty Stable
Days Of Sales Outstanding35.5858.2738.8717
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.960.84610.9667
Slightly volatile
Price To Book Ratio2.452.10962.1111
Slightly volatile
Fixed Asset Turnover27.5843.403528.4737
Slightly volatile
Enterprise Value Multiple11.0811.89329.3213
Slightly volatile
Debt Ratio0.370.34820.1445
Slightly volatile
Price Sales Ratio1.180.7391.0108
Slightly volatile
Asset Turnover1.251.50161.4697
Slightly volatile
Gross Profit Margin0.20.13340.1915
Slightly volatile
Price Fair Value2.452.10962.1111
Slightly volatile

Astrana Health Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1 B1.5 B758.6 M
Slightly volatile

Astrana Fundamental Market Drivers

Forward Price Earnings23.0415
Cash And Short Term Investments290.8 M

About Astrana Health Financial Statements

Investors use fundamental indicators, such as Astrana Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Astrana Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue1.6 M1.5 M
Total Revenue2 B2.1 B
Cost Of Revenue1.8 B1.9 B
Stock Based Compensation To Revenue 0.02  0.01 
Sales General And Administrative To Revenue 0.08  0.06 
Capex To Revenue 0.00  0.01 
Revenue Per Share 42.66  40.53 
Ebit Per Revenue 0.04  0.05 

Currently Active Assets on Macroaxis

DDDupont De Nemours
CRDOCredo Technology Group
GOOGAlphabet Inc Class C
BACBank of America
CRMSalesforce
When determining whether Astrana Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Astrana Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrana Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrana Health Stock:
How To Invest In Astrana
Details
Is Astrana Stock a good investment?
Details
What is Astrana Health's Net Worth?
Details
Largest Health Care Providers & Services Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Astrana Health Correlation against competitors.
For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.98)
Earnings Share
0.19
Revenue Per Share
59.463
Quarterly Revenue Growth
0.997
Return On Assets
0.0288
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Astrana Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Astrana Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astrana Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY